Spondyloarthritis: Criteria, limitations, and perspectives throughout history

Ankylosing Spondylitis and Axial Spondyloarthritis in Patients With Long-term Inflammatory Bowel Disease: Results From 20 Years of Follow-up in the IBSEN Study

“…In the 1990s two sets of classification criteria for SpA as a whole were published, first by Amor et al (49), then another by the European Spondyloarthropathy Study Group (ESSG) (50). Neither of these distinguished between the clinical presentation of predominantly axial or peripheral manifestations, and the validity and convenience of these criteria were debated (51). In the early 2000's the increasing use of tumor necrosis factor inhibitor (anti-TNF) and availability of magnetic resonance imaging (MRI), urged the need for an earlier detection of axial SpA, with the development of the Assessment of Spondyloarthritis International Society (ASAS) classification criteria for axial SpA in 2009 (41,52).…”

2022 French Society for Rheumatology (SFR) recommendations on the everyday management of patients with spondyloarthritis, including psoriatic arthritis

“…This diagnosis is made by a rheumatologist based on a set of arguments from the medical history, clinical examination, laboratory tests, and imaging studies. If needed, the rheumatologist may obtain additional assistance from classification systems such as the Amor criteria or Assessment of SpondyloArthritis international Society (ASAS) criteria or CASPAR criteria [4], making sure to apply the exact definitions of each item (e.g., uveitis and/or IBD must be diagnosed by a physician) [15]. The rheumatologist's degree of confidence in the diagnosis is crucial [16].…”

The Concept of Barrier Organ Disease in the Pathogenesis of Spondyloarthritis

“…Несмотря на разработку и широкое внедрение кон-цепции ранней диагностики недифференцированных форм СпА, основанной на классификационных критериях Международной рабочей группы по изучению анкилози-рующего спондилита (ASAS), заболевания из группы СпА по-прежнему представляют нерешенную серьезную про-блему для клинической практики и относятся к наиболее дискуссионным разделам ревматологии [27,28].…”